Fludarabine
Myeloid Sarcoma
St. Jude Children's Research HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
24 Active assets in the Myeloid Sarcoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cytosin-Arabinosid Kura Oncology, Inc. | Phase 3 | BB |
Mitoxantrone Ruijin Hospital | Phase 3 | BB |
Daunorubicin Kura Oncology, Inc. | Phase 3 | BB |
ETOPOSIDE St. Jude Children's Research Hospital | Phase 3 | BB |
Venetoclax Ruijin Hospital | Phase 2 | BB |
View all 32 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →